Company intelligence / Profile preview

H&H Group

Hong Kong, Hong Kong SARhh.global ↗

Ownership: Private
Employees: ~3300
Development stage: Other

Overview

H&H Group is a global leader in premium nutrition and wellness products for infants, adults, and pets. Its portfolio includes infant formula, adult dietary supplements (notably under the Swisse brand), probiotics/prebiotics/postbiotics for gut health and immunity support. The group sponsors clinical research to validate product efficacy—such as demonstrating that Swisse High Strength Deep Sea Krill Oil can relieve pain in mild to moderate knee osteoarthritis. As of September 2024, revenue was approximately USD 1.32 billion.

Therapeutic areas: Metabolic DisordersOther
Modalities: Probiotic supplementNutritional supplement (including vitamins, minerals, omega 3 fatty acids)
Industry: Food & Nutrition

Partnerships

CSIRO (Commonwealth Scientific and Industrial Research Organisation)Aker BioMarine

Beyond the preview

Go deeper on H&H Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on H&H Group.

Explore the full profile